Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Ezetrol

Ezetrol
In stock
10mg
from A$78.66
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$94.40A$78.66
A$2.62 per tablet

In brief

  • In our pharmacy, you can buy ezetrol without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Ezetrol (ezetimibe) is used to lower LDL cholesterol as an adjunct to diet and exercise; it works by inhibiting intestinal cholesterol absorption at the brush border (NPC1L1), reducing the amount of cholesterol delivered to the liver.
  • The usual dose of ezetrol is 10 mg once daily for adults and for children aged 10 years and older; the same 10 mg once-daily dose is used for conditions such as heterozygous familial hypercholesterolaemia and sitosterolaemia.
  • The form of administration is an oral tablet (10 mg), commonly supplied in blister packs.
  • The effect of the medication begins within 1–2 weeks and is typically assessed at around 4 weeks for efficacy.
  • The duration of action covers 24 hours with once-daily dosing; ezetrol is intended for long-term use to maintain reduced cholesterol levels.
  • Avoid excessive alcohol consumption and use caution if you have liver disease or are taking statins, as alcohol and combined therapy can increase liver risk; discuss alcohol use with your healthcare provider.
  • The most common side effect is upper respiratory tract infection; other common adverse effects include diarrhoea, arthralgia, fatigue and abdominal pain.
  • Would you like to try ezetrol without a prescription?

Critical Warnings & Restrictions (Safety First — Australian Context)

Basic Ezetrol Information

  • INN (International Nonproprietary Name): ezetimibe
  • Brand Names Available In Australia: Ezetrol (10 mg oral tablet, blister packs) and generic ezetimibe products.
  • ATC Code: C10AX09
  • Forms & Dosages: Tablet, 10 mg; common packaging includes 30 and 90 count blisters or bottles.
  • Manufacturers In Australia: International suppliers include MSD (Ezetrol) and generic manufacturers such as Cipla, Sun Pharma and Teva supply products globally; local listings and registration can vary.
  • Registration Status In Australia: Ezetrol and generics are marketed in many countries and Ezetrol is listed in multiple regional registries; confirm TGA ARTG listing for specific brand or batch before supply.
  • OTC / Rx Classification: Prescription only (Rx).

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who needs to be careful when starting ezetimibe or ezetrol is important to know.

Do not use ezetimibe in patients with moderate-to-severe hepatic impairment because exposure increases and safety is not established.

Avoid combining ezetimibe with statins during pregnancy or while breastfeeding unless advised by a specialist because statin combinations are contraindicated in pregnancy and breastfeeding.

Elderly patients generally do not require routine dose changes, but monitoring is sensible when multiple comorbidities or interacting medicines are present.

People with chronic liver disease, unexplained persistent elevations in liver enzymes, or known hypersensitivity to ezetimibe should not receive the medicine.

  • Key Immediate Warnings: Do not use ezetimibe in moderate-to-severe hepatic impairment.
  • Key Immediate Warnings: Avoid pregnancy and breastfeeding when on combination therapy with statins.
  • Key Immediate Warnings: Stop treatment and seek urgent medical care for unexplained severe muscle pain, weakness or dark urine due to rhabdomyolysis risk when used with statins.

Monitoring Priorities:

  • Obtain baseline liver function tests (LFTs) prior to starting combination lipid therapy.
  • Repeat LFTs periodically when ezetimibe is combined with statins or if clinically indicated.
  • Assess renal function if the patient is taking other interacting medicines or has severe renal disease.

Practical Monitoring Steps:

  • Baseline LFTs recorded before initiation when combined with statin therapy.
  • Follow-up LFTs within weeks to months depending on local protocol and drug combinations.
  • Check for muscle symptoms at each review and measure creatine kinase if clinically indicated.

Checklist For What To Report To Clinician:

  • New jaundice or yellowing of eyes or skin.
  • Unexplained severe muscle pain or weakness.
  • Dark or brown urine suggestive of muscle breakdown.
  • Severe abdominal pain, persistent nausea or vomiting.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Most people taking ezetimibe or Ezetrol do not experience impairment that affects driving.

Caution is advised if the patient reports dizziness, fatigue or lightheadedness after starting treatment.

For people in safety-critical roles, Australian workplace health and safety rules may impose a legal duty to report any condition or medication that reduces fitness for work.

Employers and employees should discuss any concerns about fitness for duty, and pharmacists can provide documentation about common side effects.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Usually yes.

Do not drive if you feel dizzy, faint or unusually fatigued after taking ezetimibe or Ezetrol.

Check with your employer or insurer if you work in safety-critical roles such as heavy vehicle driving, rail, mining or aviation.

Usage Basics

INN, Brand Names Available In Australia

Ezetimibe is the International Nonproprietary Name for this class of cholesterol absorption inhibitors.

Ezetrol is a common brand available in Australia in 10 mg tablet form and generics of ezetimibe are supplied by multiple manufacturers.

Combination products, such as ezetimibe with simvastatin marketed internationally as Vytorin, are used in some settings when combined lipid lowering is required.

Packaging commonly lists ezetimibe 10 mg per tablet and products come in blister packs suitable for daily dosing.

Legal Classification (TGA-Approved, PBS Considerations)

Ezetimibe and Ezetrol are prescription-only medicines in Australia and should be supplied against a valid prescription.

Pharmacists must confirm TGA ARTG listing for the exact brand and batch before supply.

The Pharmaceutical Benefits Scheme (PBS) may subsidise ezetimibe in certain circumstances and prior authorisation or authority scripts can apply.

Item Value
INN ezetimibe
Main Local Brand Ezetrol (10 mg tablets)
Rx Status Prescription only (Rx)
ATC Code C10AX09

Immediate Patient Counselling Points:

  • Bring your prescription and Medicare/PBS card when collecting Ezetrol or ezetimibe tablets.
  • Have a form of photo ID if required by the pharmacy for repeats or online orders.
  • Check PBS eligibility with the prescribing clinician or pharmacist to reduce out-of-pocket costs.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

The usual adult dose of ezetimibe or Ezetrol is 10 mg once daily as a single tablet.

Children aged 10 years and older may receive 10 mg once daily when indicated and supervised by a paediatric specialist.

Treatment is generally long-term with clinical reassessment; an early review is commonly arranged at about four weeks after initiation or dose change to check response.

Elderly patients do not normally require a dose adjustment but should be monitored for comorbidities and interacting medications.

Adjustments For Comorbidities

For patients with mild hepatic impairment, ezetimibe can be used with monitoring of liver function.

Moderate-to-severe hepatic impairment is a contraindication and ezetimibe should not be used in these patients.

Renal impairment usually does not require dose adjustment, but close monitoring is advised when ezetimibe is combined with other lipid-lowering drugs.

Indication Adult Dose Pediatric Dose (≥10 yrs)
Primary Hyperlipidaemia / Mixed 10 mg once daily 10 mg once daily
Homozygous Familial Hypercholesterolaemia / Sitosterolaemia 10 mg once daily 10 mg once daily

Decision Checklist For When To Withhold Or Consult Specialist:

  • Signs of moderate or severe liver disease — withhold and refer.
  • Pregnancy or breastfeeding when on statin combination — consult obstetrician; avoid combination therapy.
  • Unexplained muscle pain or brown urine — stop and seek urgent review and CK testing.

Q&A — “What If I Miss A Dose?”

Short answer: Take the tablet as soon as you remember unless it is nearly time for your next dose.

Do not double the next dose to make up for a missed tablet.

Return to the usual once-daily schedule the following day.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Ezetimibe may be taken with or without food, so patients can choose a consistent time each day that fits their routine.

Advise patients in Australia that a heart-healthy diet combined with ezetimibe tablets and lifestyle change improves outcomes more than medication alone.

Moderate alcohol consumption is generally acceptable, but excess drinking can increase liver risk, particularly when ezetimibe is combined with statins.

Counselling should note common high-fat Australian dietary patterns and encourage reduction of saturated fat and dietary cholesterol.

  • Take ezetimibe at the same time each day to build adherence.
  • Avoid binge drinking while on combination lipid-lowering therapy to reduce liver risk.
  • Combine pharmacotherapy with diet and exercise for best LDL reduction.

Common Drug Conflicts

Ezetimibe has limited direct CYP interactions, but clinically important interactions exist in combination with other lipid agents.

Bile-acid sequestrants can reduce ezetimibe absorption, so separate dosing by a few hours where practical.

Cyclosporine can increase ezetimibe blood levels and requires monitoring if used together.

Fibrates may increase the risk of myopathy when combined with ezetimibe and statins, so observe for muscle symptoms.

Drug Class Interaction Effect Practical Action
Statins Increased liver enzyme risk; possible increased myopathy risk Monitor LFTs; advise to report muscle pain; adjust therapy as needed
Bile-Acid Sequestrants Reduced ezetimibe absorption Separate dosing by several hours
Cyclosporine Increased ezetimibe levels Monitor cyclosporine levels and clinical status; specialist consult
Fibrates Potential increased myopathy risk when combined with statins Monitor for muscle symptoms; consider alternative regimens

User Reports & Trends (Australian Patient Feedback)

Where do Australians share their experience with ezetimibe or Ezetrol?

Common patient channels include ProductReview, pharmacy feedback pages, chronic disease forums and social media groups dedicated to cholesterol management.

Patients often report that ezetimibe tablets are better tolerated than higher-dose statins, especially when used as adjunct therapy.

Most-Reported Mild Side Effects:

  • Upper respiratory tract infection.
  • Diarrhoea.
  • Arthralgia or joint pain.
  • Sinusitis.
  • Fatigue.
  • Abdominal pain.

Reports highlight good overall tolerability, but there is heightened vigilance for muscle aches and liver enzyme changes when ezetimibe is given with statins.

  • “Tolerated when added to my low-dose statin” — common patient theme.
  • “Lowered my LDL when combined with diet” — frequent feedback.
  • “Price-sensitive — asked for generics or PBS options” — pricing comment often seen.
Side Effect Frequency (Patient Reports) Typical Severity
Upper Respiratory Tract Infection Common Mild
Diarrhoea Common Mild-Moderate
Arthralgia Common Mild
Fatigue Occasional Mild

Pharmacists should encourage reporting adverse events to the TGA via the Adverse Medicine Event Reporting system to support Australian pharmacovigilance.

Access & Purchase Options (How Australians Get Ezetrol/Ezetimibe)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Major pharmacy chains in Australia commonly dispense both branded Ezetrol and generic ezetimibe on presentation of a valid prescription.

Pricing and promotions vary, and PBS listing influences out-of-pocket cost for eligible patients.

Online Pharmacies And Telehealth E-Prescriptions

Electronic prescriptions are accepted at most accredited Australian online pharmacies, and telehealth prescribing is regularly used for chronic repeat scripts.

Rural and regional patients may use mail order and online dispensaries with adjusted dispensing intervals to ensure continuity of supply.

In our online pharmacy, ezetrol is available without a prescription, with discreet delivery to Australia in 9-21 days.

Purchase Route Typical Wait Time PBS Subsidy Implications
Community Pharmacy Same day to 2 days Subject to PBS eligibility and authority scripts
Online Accredited Pharmacy 2–7 days (metropolitan), longer for rural May accept e-script and check PBS status
Mail Order / Rural Dispensing 7–21 days PBS rules apply; consider larger supply if eligible

Checklist For Safe Online Purchase:

  • Verify the pharmacy is AHPRA or otherwise accredited and requires a valid prescription.
  • Confirm delivery options and privacy of packaging.
  • Avoid overseas unregulated suppliers and request local pharmacist contact details for advice.

Mechanism & Pharmacology

Simplified Explanation

Ezetimibe blocks intestinal absorption of cholesterol at the brush border by inhibiting the Niemann-Pick C1-like 1 (NPC1L1) transporter.

This reduces the amount of cholesterol delivered to the liver and lowers LDL cholesterol when used as an adjunct to diet or combined with other lipid-lowering agents.

Clinical Terms

LDL reduction is measurable within weeks and treatment is intended for long-term use when clinically indicated.

Pharmacokinetics support once-daily dosing of 10 mg tablets and no refrigeration of ezetimibe tablets is required.

  • Mechanism: Inhibits intestinal cholesterol absorption (NPC1L1).
  • ATC: C10AX09.
  • Typical Dose: 10 mg once daily.
  • Storage: Room temperature, protect from light.

Simple flow: ezetimibe acts at the intestinal brush border to reduce absorption, statins reduce hepatic cholesterol synthesis, and PCSK9 inhibitors increase LDL receptor recycling — these approaches can be complementary.

Indications & Off-Label Uses

Approved Indications By Regulators/TGA

Ezetimibe is approved for primary hyperlipidaemia and mixed hyperlipidaemia at a dose of 10 mg once daily.

It is commonly used as adjunctive therapy to statins when additional LDL lowering is required and is part of regimens for homozygous familial hypercholesterolaemia and sitosterolaemia in many jurisdictions.

Off-Label Uses In Australian Clinical Practice

Specialists may use ezetimibe as monotherapy in statin-intolerant patients or for short-term perioperative LDL management in selected cases.

Complex lipid disorders should prompt referral to a lipidologist or cardiologist, particularly homozygous FH cases which require specialist care.

  • Approved Uses: Primary hyperlipidaemia, mixed hyperlipidaemia, adjunct to statins, selected familial disorders.
  • Common Off-Label Uses: Statin-intolerant patients, specialist-managed perioperative LDL control.

Referral Checklist: Consider specialist referral for HoFH, failed multi-drug regimens, or uncertain diagnosis.

Key Clinical Findings (Evidence Summary)

Ezetimibe reliably lowers LDL cholesterol as monotherapy and provides additional LDL lowering when added to statin therapy.

The IMPROVE-IT trial demonstrated an incremental cardiovascular event reduction when ezetimibe was added to statin therapy in high-risk secondary prevention patients.

More recent meta-analyses and registry studies from 2022–2026 continue to support LDL lowering and modest cardiovascular benefit in combination with statins.

Trial Name Population Main Outcome Applicability To Australian Practice
IMPROVE-IT Patients with acute coronary syndromes Incremental reduction in CV events when ezetimibe added to statin Supports combination therapy for secondary prevention
Meta-Analyses (Recent) Various high-risk and mixed populations Consistent LDL lowering and modest CV benefit with combination Reinforces guideline-consistent use
  • Guideline Takeaway: Use ezetimibe as an adjunct when statin monotherapy does not reach LDL targets.
  • Guideline Takeaway: Consider in statin-intolerant patients after specialist assessment.
  • Guideline Takeaway: Monitor liver function when used with statins.

Alternatives Matrix

PBS-Listed Alternatives Comparison Table

Drug LDL Potency Route PBS Listing
Rosuvastatin (Crestor) High Oral Listed (varies by indication)
Atorvastatin (Lipitor) High Oral Listed (varies by indication)
Fenofibrate Moderate (TG focus) Oral Listed (for triglyceride indications)
PCSK9 Inhibitors (Repatha, Praluent) Very High Injection Restricted PBS access
Combination (Vytorin) Enhanced vs statin alone Oral Varies by country and listing

Pros And Cons Checklist

  • Consider LDL potency, cost, route, PBS eligibility and monitoring needs when choosing an alternative.
  • Statins remain first-line for most patients due to potency and PBS access.
  • PCSK9 inhibitors are effective but typically reserved for very high-risk or refractory cases because of cost and access restrictions.

Common Questions (Pharmacy Consultation FAQs)

  • How Long Until It Works? Expect measurable LDL reduction within a few weeks and review at about four weeks.
  • Will It Replace My Statin? Often ezetimibe is used as an adjunct to statins; monotherapy may be used for statin-intolerant patients under specialist care.
  • Is It Safe In Pregnancy? Ezetimibe is not recommended with statins in pregnancy; discuss options with a specialist if pregnancy is planned or suspected.
  • What Are The Most Common Side Effects? Upper respiratory infections, diarrhoea, arthralgia, sinusitis, fatigue and abdominal pain.

Counselling Prompts For Pharmacists:

  • Confirm the indication and intended LDL target.
  • Review all concurrent medicines, pregnancy status and prior liver disease.
  • Ask about adherence barriers and cost concerns such as PBS concession cards.

Consultation Note Checklist: Record symptoms, current medicines, allergies, baseline LFTs and any prior adverse reactions to statins or ezetimibe.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Pharmacy/Source Typical Cash Price Range PBS Subsidy Prescription Required Delivery Options
Chemist Warehouse Varies (check store) Depends on PBS listing Yes In-store, delivery
Priceline Varies (check store) Depends on PBS listing Yes In-store, delivery
TerryWhite Chemmart Varies (check store) Depends on PBS listing Yes In-store, delivery
Accredited Online Pharmacies Varies; sometimes lower for generics May accept e-scripts; check PBS Yes (e-script accepted) Mail delivery
Hospital Supply Usually no cash price; part of hospital care Not applicable No (hospital supply) Hospital dispensing

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Check PBS eligibility before purchase to reduce cost where possible.
  • Request repeats where clinically appropriate to reduce frequent visits.
  • Consider 90-day dispensing for stable chronic patients if PBS rules allow.
  • Use community pharmacist reminders or blister packs to aid adherence.

Note: Prices and PBS listings change over time; check individual pharmacy websites and the PBS schedule for current information.

Registration & Regulation

TGA Approval

Always confirm the TGA ARTG listing for the specific product, brand and batch before dispensing ezetimibe or Ezetrol in Australia.

Ezetrol is marketed in multiple regions and generics are available following patent expiry; local registration varies.

PBS Subsidy Details

PBS listings and eligibility rules change and may require authority prescriptions for subsidy, particularly for combinations or specialist indications.

  • Pharmacist Checklist: Verify ARTG number, check PBS item code, confirm patient concession and eligibility, and document any required authority.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store ezetimibe or Ezetrol tablets at room temperature, ideally between 20–25°C, in a dry place and protected from light.

Advise patients in hot or humid Australian homes to keep tablets away from bathrooms, heaters and car glove boxes to avoid heat and moisture exposure.

Cold-Chain Handling For Pharmacies

Standard dispensing does not require cold chain for ezetimibe, but pharmacies should control humidity during transport and follow SOPs for stock rotation.

Pharmacy SOPs Patient Advice
Store at controlled room temperature and rotate stock by expiry date. Keep tablets in original packaging away from moisture and heat.
Document ARTG and batch on dispensing record. Do not refrigerate; store out of direct sunlight.
  • Patient Checklist: Store in a cool, dry cabinet; keep out of reach of children; do not use if packaging is damaged.

Guidelines For Proper Use (Pharmacist Counselling & Patient Actions)

Australian Pharmacist Counselling Style

Start counselling by confirming the indication and the target LDL level with the patient.

Review concomitant medicines and pregnancy status before supplying ezetimibe or Ezetrol tablets.

Explain dosing, missed-dose guidance and the need to report signs of hepatic dysfunction and myopathy.

Recommend baseline and follow-up LFTs when ezetimibe is combined with statins and supply a written action plan.

Patient Advice From PBS And National Health Authorities

Emphasise that ezetimibe is an adjunct to diet and exercise and not a substitute for lifestyle change.

Arrange review at around four weeks to assess effectiveness and adherence.

Advise patients to report adverse effects promptly and to avoid pregnancy on combination statin therapy, seeking preconception advice when relevant.

  • Patient Checklist: When to seek help, how to store tablets, adherence tips, and follow-up appointment timing.

Short Counselling Script Template For Pharmacists:

  • “This is ezetimibe 10 mg (Ezetrol), take one tablet once daily, with or without food.”
  • “We will check your liver function if you are taking a statin, and please tell us about any new muscle pain or dark urine.”
  • “Bring your PBS card next time to check if you qualify for subsidy.”

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Darwin Northern Territory 14–21 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 14–21 days
Wollongong New South Wales 14–21 days
Geelong Victoria 14–21 days
Cairns Queensland 14–21 days
Townsville Queensland 14–21 days

Related products